Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 8Recruiting 5Unknown 4Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 95Fluorouracil 84Capecitabine 75Gemcitabine 72Leucovorin 68Nivolumab 67Bevacizumab 63pembrolizumab 60Magnetic Resonance Spectroscopy 52Specimen Handling 50Irinotecan 50durvalumab 46Radiotherapy 42atezolizumab 40Cisplatin 39Paclitaxel 37Biopsy 37130-nm albumin-bound paclitaxel 34Cetuximab 30Carboplatin 27Albumin-Bound Paclitaxel 26Taxes 24Drug Therapy 20dehydroftorafur 19Radiation 19Ipilimumab 19tislelizumab 18Surgical Procedures, Operative 17Standard of Care 17Docetaxel 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Hematologic Tests × Gastrointestinal × Clear all
NCT06929481 2026-05-28

Screening With a DNA Blood Test to Address Colorectal Cancer Inequities

University of California, San Diego

Phase NA Active not recruiting
340 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06730035 2024-12-12

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Active not recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡